Amica Retiree Medical Trust trimmed its position in Citigroup (NYSE:C) by 32.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,753 shares of the financial services provider’s stock after selling 7,082 shares during the quarter. Citigroup comprises 0.8% of Amica Retiree Medical Trust’s holdings, making the stock its 20th largest position. Amica Retiree Medical Trust’s holdings in Citigroup were worth $1,098,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Sawyer & Company Inc purchased a new position in Citigroup during the fourth quarter valued at approximately $117,000. Baldwin Brothers Inc. MA raised its position in Citigroup by 88.4% during the fourth quarter. Baldwin Brothers Inc. MA now owns 1,598 shares of the financial services provider’s stock valued at $119,000 after acquiring an additional 750 shares in the last quarter. Balentine LLC raised its position in Citigroup by 20.2% during the second quarter. Balentine LLC now owns 1,617 shares of the financial services provider’s stock valued at $108,000 after acquiring an additional 272 shares in the last quarter. Lee Financial Co raised its position in Citigroup by 57.0% during the fourth quarter. Lee Financial Co now owns 2,240 shares of the financial services provider’s stock valued at $167,000 after acquiring an additional 813 shares in the last quarter. Finally, Risk Paradigm Group LLC raised its position in Citigroup by 692.0% during the second quarter. Risk Paradigm Group LLC now owns 2,281 shares of the financial services provider’s stock valued at $153,000 after acquiring an additional 1,993 shares in the last quarter. Hedge funds and other institutional investors own 80.21% of the company’s stock.
Shares of Citigroup stock opened at $73.47 on Monday. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market capitalization of $188,822.75, a P/E ratio of -23.70, a PEG ratio of 1.06 and a beta of 1.51. Citigroup has a 12 month low of $56.55 and a 12 month high of $80.70.
Citigroup (NYSE:C) last released its quarterly earnings data on Tuesday, January 16th. The financial services provider reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.09. The company had revenue of $17.26 billion for the quarter, compared to analyst estimates of $17.23 billion. Citigroup had a positive return on equity of 7.61% and a negative net margin of 7.05%. The firm’s revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 earnings per share. research analysts predict that Citigroup will post 6.41 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, February 23rd. Shareholders of record on Monday, February 5th were paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 1.74%. The ex-dividend date was Friday, February 2nd. Citigroup’s dividend payout ratio (DPR) is currently -41.29%.
C has been the subject of a number of recent analyst reports. ValuEngine upgraded Citigroup from a “buy” rating to a “strong-buy” rating in a research report on Friday, February 9th. Keefe, Bruyette & Woods boosted their price objective on Citigroup from $80.00 to $87.00 and gave the company an “outperform” rating in a research report on Thursday, December 14th. DZ Bank upgraded Citigroup from a “hold” rating to a “buy” rating in a research report on Wednesday, February 7th. Nomura set a $87.00 price objective on Citigroup and gave the company a “buy” rating in a research report on Wednesday, January 17th. Finally, Vetr cut Citigroup from a “sell” rating to a “strong sell” rating and set a $70.80 price objective for the company. in a research report on Monday, January 29th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and fifteen have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $79.69.
ILLEGAL ACTIVITY NOTICE: “Citigroup (C) Shares Sold by Amica Retiree Medical Trust” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/03/19/citigroup-c-shares-sold-by-amica-retiree-medical-trust.html.
Citigroup Inc, a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions. The company operates through two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG). The GCB segment offers traditional banking services to retail customers through retail banking, commercial banking, Citi-branded cards, and Citi retail services.
Want to see what other hedge funds are holding C? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Citigroup (NYSE:C).
Receive News & Ratings for Citigroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citigroup and related companies with MarketBeat.com's FREE daily email newsletter.